The Recall Desk
SevereFDA (Devices)·Z-2572-2020·Announced 2020-07-22

CME America BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy

CME America is recalling BodyGuard Microset infusion sets because they may deliver therapy at inaccurate rates, potentially causing over-infusion or under-infusion.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric, as the device defect poses a risk of serious injury through incorrect therapy delivery.

Plain-English summary

CME America, LLC is recalling BodyGuard Microset with Filter (REF: A100-164XESF) infusion administration sets. The recall involves 55,455 units distributed across the United States and in Canada and the UK.

The recall is due to a delivery inaccuracy in the infusion sets, which may range from minus 42.8% to plus 17.5% (over plus/minus 13%). The use of these infusion pump systems could cause over-infusion or under-infusion of therapy.

Healthcare facilities and consumers who have these products should stop using them and contact CME America, LLC for instructions on return or replacement.

The recalled product

Product
BodyGuard Microset with Filter, REF: A100-164XESF
Manufacturer
CME America, LLC
Affected units
55,455

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Part of a larger recall action

This product is one of 37 recalled by CME America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 37 products in this recall →